Clinical Trials Browser

Not yet recruiting × Thoracic × Clear all

NCT07459634 2026-05-27

A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma

NCT07509034 2026-05-27

Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease

Phase 1 Not yet recruiting

Recurrence, Small Cell Lung Carcinoma

NCT07599943 2026-05-27

LungSMART

Phase NA Not yet recruiting

18,894 enrolled

Lung Neoplasms

NCT07600801 2026-05-27

LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol B

Not yet recruiting

Lung Neoplasms

NCT07608159 2026-05-27

Neoadjuvant SF-SBRT Plus Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC.

Phase 3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07609121 2026-05-27

Hypofractionated Chemoradiotherapy With Tislelizumab and Surufatinib for Unresectable Stage III NSCLC

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07609251 2026-05-27

A Clinical Study of SCTB41 Combined With Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer（Phase II Study Ongoing）

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06745258 2026-05-26

ICARE-LCS

Not yet recruiting

Lung Neoplasms

NCT06813664 2026-05-22

CURB-TKI

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07355205 2026-05-22

FLINN

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07490860 2026-05-22

A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial

Phase NA Not yet recruiting

Lung Neoplasms

NCT07601048 2026-05-22

A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment

Phase 3 Not yet recruiting

KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment

NCT07602946 2026-05-22

SELECTmeso

Phase 2 Not yet recruiting

Other solid neoplasmThoracic

Mesothelioma

NCT07603661 2026-05-22

Sintilimab Plus Chemotherapy as Induction Therapy for Unresectable Stage IIIC NSCLC

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07603791 2026-05-22

Phase II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of ALK202 for Injection in Combination With Drugs in NSCLC Participants.

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07603856 2026-05-22

REVIVE

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06708221 2026-05-20

Real-Time IGRT

Phase NA Not yet recruiting

Breast Neoplasms, Lung Neoplasms, Neoplasms

NCT07513818 2026-05-20

IMPULSION

Phase NA Not yet recruiting

20,000 enrolled

Lung Neoplasms, Smoking Cessation

NCT07598279 2026-05-20

PVD-Lungs

Phase NA Not yet recruiting

Lung Neoplasms, Peripheral Vascular Diseases

NCT07599007 2026-05-20

Repotrectinib Post-Marketing Surveillance in Korean Patients With ROS1-Positive Non-Small Cell Lung Cancer (NSCLC) or Solid Tumors Harboring a Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion

Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07599163 2026-05-20

Oral Paclitaxel as Neoadjuvant Therapy in Elderly NSCLC: A Phase II Trial

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07486817 2026-05-19

Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab

Phase 2 Not yet recruiting

Lung Neoplasms

NCT07588347 2026-05-19

Construction and Preliminary Evaluation of Dyadic Acceptance and Commitment Therapy for Couples With Fear of Lung Cancer Recurrence

Phase NA Not yet recruiting

Lung Neoplasms

NCT07594834 2026-05-19

Clinical Study on the Effects of Pulmonary Vessels on Cryoablation and Preventive Embolization Strategies

Phase NA Not yet recruiting

Lung Neoplasms

NCT07595120 2026-05-19

Application of Electromagnetic Navigation System in Pulmonary Nodule Localization

Phase NA Not yet recruiting

Lung Neoplasms, Multiple Pulmonary Nodules

NCT07596524 2026-05-19

Analysis of Different Second Line Treatment in Advanced NSCLC Patients Progressing After 1st Line Immune Checkpoint Inhibitor Therapy

Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07596732 2026-05-19

SUNRISE

Phase NA Not yet recruiting

GastrointestinalThoracic

Colonic Neoplasms, Disease, Esophageal Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

NCT07597070 2026-05-19

UNIFIER

Phase 2/3 Not yet recruiting

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT07014878 2026-05-18

A Study of DCTY1102 Injection in Participants With Advanced Solid Tumors

Phase 1 Not yet recruiting

GastrointestinalThoracic

Lung Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT07590596 2026-05-18

Preoperative Decision-Making in Patients With Pulmonary Nodules Suspected of Lung Cancer

Not yet recruiting

Pulmonary Nodule

NCT07593248 2026-05-18

ECHO

Not yet recruiting

Lung Neoplasms

NCT07593872 2026-05-18

XR-NeckLND

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lymphatic Metastasis

NCT07594067 2026-05-18

TCR1188-ABC Cells in KRAS-mutated Cancers

Phase 1 Not yet recruiting

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Cholangiocarcinoma

NCT07460440 2026-05-15

SPARC

Phase NA Not yet recruiting

Lung Neoplasms

NCT07541170 2026-05-15

KRASCENDO 3

Phase 3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07589101 2026-05-15

5T4 Targeting Nanobody Probe for PET Imaging in Solid Tumors

Phase NA Not yet recruiting

Breast Neoplasms, Lung Neoplasms

NCT07590440 2026-05-15

ILST

Phase NA Not yet recruiting

Lung Neoplasms

NCT07590531 2026-05-15

AMT-116 in Combination With Ivosidan in Patients With Lung Cancer

Phase 1/2 Not yet recruiting

Advanced Non-small Cell Lung Cancer (NSCLC)

NCT07542210 2026-05-14

SECURE

Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07586202 2026-05-14

AmiNA

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06982222 2026-05-13

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

Phase 1 Not yet recruiting

BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Prostatic Neoplasms

NCT07169617 2026-05-13

Testing the SurVaxM Vaccine for Lung Cancer Prevention

Phase 2 Not yet recruiting

Lung Neoplasms

NCT07376382 2026-05-13

SYNSTAR-02

Phase 3 Not yet recruiting

NSCLC

NCT07388524 2026-05-13

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Phase 3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07583316 2026-05-13

A Phase 1 First-in-Human Study of CRPA1A2, a MAGE-A1/HLA-A*02:01 Bispecific T-Cell Engager, in Patients With Solid Tumors

Phase 1 Not yet recruiting

GastrointestinalHead & NeckThoracic

Esophageal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Neoplasm Metastasis

NCT07583771 2026-05-13

A Phase Ⅰ Study of CS08399 in Participants With MTAP-deleted Solid Tumors and Lymphoma

Phase 1 Not yet recruiting

LymphoidThoracic

Carcinoma, Non-Small-Cell Lung, Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT07579221 2026-05-12

Ph1/2 Trial Of Navlimetostat With Pumitamig In MTAP-Deficient Advanced Non-Small Cell Lung Cancer

Phase 1/2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07412262 2026-05-08

NSCLC， YAP

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07574684 2026-05-08

ALA /NSCLC

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Disease Progression

NCT07576725 2026-05-08

Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial

Phase 2 Not yet recruiting

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidSarcomaThoracic

Clear-cell metastatic renal cell carcinoma, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Basal Cell, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Hodgkin Disease, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Sarcoma, Kaposi, Colorectal Neoplasms, Carcinoma, Merkel Cell